Gao Qiang, Nie Huaili, Zhu Chunyan, Kuang Naifeng, Wang Xiaoyu, Chen Yiqian, Zhang Xiao, Zheng Dali, Xia Qing, Yin Tao, Pan Limin, Xie Liangzhen
Taian City Central Hospital.
Taian Sanatorium of Shandong Province, Taian.
Medicine (Baltimore). 2020 Jun 5;99(23):e20527. doi: 10.1097/MD.0000000000020527.
Shoulder-hand syndrome (SHS) is a common complication in post-stroke patients. SHS has a large impact on patients and their families, communities, healthcare systems and businesses throughout the world. Non-pharmaceutical therapy for post-stroke SHS is the most common treatment in clinical practice, but their effectiveness is still unclear. The aim of this study is to assess the effect and safety of non-pharmaceutical therapeutic strategies for post-stroke SHS.
We will search 3 in English and 4 in Chinese languages electronic databases regardless of publication date or language. We will include randomized controlled trials (RCTs) assessing the effect of any non-pharmaceutical therapy for post-stroke SHS. Primary outcomes will be any effective instrument for post-stroke SHS. Two authors will independently assess the risk of bias by using Cochrane tool of risk of bias. We will perform network meta-analysis in random effects model to estimate the indirect and mixed effects of different therapeutic strategies by R-3.5.1 software. We will assess the confidence in cumulative evidence by Grading of Recommendations Assessment, Development and Evaluation.
This study will be to assess the effect and safety of non-pharmaceutical therapy for post-stroke SHS.
This study will assess the effect of different non-pharmaceutical therapeutic strategies for post-stroke SHS and provide reliable evidence for the choice of treatments.Systematic review registration: PROSPERO (CRD42019139993).
肩手综合征(SHS)是中风后患者的常见并发症。SHS对世界各地的患者及其家庭、社区、医疗保健系统和企业都有很大影响。中风后SHS的非药物治疗是临床实践中最常用的治疗方法,但其有效性仍不明确。本研究的目的是评估中风后SHS非药物治疗策略的效果和安全性。
我们将检索3个英文和4个中文电子数据库,不考虑出版日期或语言。我们将纳入评估任何中风后SHS非药物治疗效果的随机对照试验(RCT)。主要结局将是任何用于中风后SHS的有效工具。两位作者将使用Cochrane偏倚风险工具独立评估偏倚风险。我们将在随机效应模型中进行网络荟萃分析,以通过R-3.5.1软件估计不同治疗策略的间接和混合效应。我们将通过推荐分级评估、制定和评价来评估累积证据的可信度。
本研究将评估中风后SHS非药物治疗的效果和安全性。
本研究将评估不同中风后SHS非药物治疗策略的效果,并为治疗选择提供可靠证据。系统评价注册:PROSPERO(CRD42019139993)。